Dr. Gary Allred
Co-founder, President and CEO
Dr. Gary Allred is co-founder, President and CEO of Synthonix Corporation. In addition to his extensive chemical and pharmaceutical expertise, Dr. Allred has over 15 years of experience in business development and management, intellectual property development, patent filing and prosecution, strategic and portfolio planning, contract negotiation, technology assessment, and competitive intelligence. Before co-founding Synthonix Corporation in 2003, Dr. Allred founded a successful startup in 1997 where he served as President and CEO. Prior to this he received his Ph.D. in organic chemistry from Emory University under Dr. Lanny Liebeskind. Dr. Allred performed research in copper-mediated and palladium-catalyzed coupling reactions, boron chemistry, and silane chemistry. He authored several papers in peer-reviewed journals and is an inventor of seven patents.
Jonathan Scoggins is the co-founder of Synthonix Inc. He currently serves as Vice President of Synthonix. Jonathan has over 12 years of experience in the custom chemical business. Jonathan’s main focus with Synthonix is business management and business development. Before co-founding Synthonix Inc. Jonathan founded Ryscor Science Inc in 1998 where he served as President and CEO until starting Synthonix in 2003. Ryscor Science was a specialty chemical company that specialized in boronic acids as well as other boron containing compounds used in various areas of medicinal research and development. When Ryscor Science was formed the core focus was supplying boron-10 labeled amino acids for use in BNCT (boron neutron capture therapy) which was and still is a promising therapy for use on various types of malignant brain tumors. Jonathan received his undergraduate degree from North Carolina State University in 1996.
Dr. Haydn Boehm
COO, Synthonix Ltd.
Haydn is a global marketing and sales professional with over 13 years in the pharmaceutical industry with expertise in strategic marketing, product management, marketing communications, sales management as well as business and sales development. Before joining Synthonix Ltd. Haydn was the Global Marketing Manager for Aldrich Chemistry and Johnson Matthey Catalysis and Chiral Technologies. Haydn’s earlier career began with a PhD from the University of Nottingham (UK), under the supervision of Prof. Gerry Pattenden, which focused on radical mediated cyclization reactions. After his PhD Haydn worked as a Senior Scientist at Evotec in Oxfordshire (UK) developing compound libraries for major pharmaceuticals, before taking on more commercial roles within the chemical industry.